home / stock / pcrx / pcrx quote
Last: | $31.51 |
---|---|
Change Percent: | -0.03% |
Open: | $30.09 |
Close: | $31.51 |
High: | $31.65 |
Low: | $29.96 |
Volume: | 798,521 |
Last Trade Date Time: | 05/16/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$31.51 | $30.09 | $31.51 | $31.65 | $29.96 | 798,521 | 05-16-2024 |
$30.08 | $31.18 | $30.08 | $31.6 | $30.01 | 684,354 | 05-15-2024 |
$30.82 | $30.62 | $30.82 | $31.1 | $30.22 | 1,180,556 | 05-14-2024 |
$30.38 | $29.79 | $30.38 | $30.82 | $29.79 | 1,242,953 | 05-13-2024 |
$29.42 | $29.86 | $29.42 | $30.7 | $29.14 | 5,644,229 | 05-10-2024 |
$29.86 | $28.9 | $29.86 | $30.475 | $28.9 | 2,347,475 | 05-09-2024 |
$29.65 | $28.9 | $29.65 | $30.59 | $28.25 | 1,959,533 | 05-08-2024 |
$26.51 | $26.75 | $26.51 | $27.27 | $26.43 | 734,470 | 05-07-2024 |
$26.5 | $27.45 | $26.5 | $27.86 | $26.47 | 733,744 | 05-06-2024 |
$27.21 | $27.68 | $27.21 | $27.77 | $27.05 | 247,316 | 05-03-2024 |
$27.32 | $27.27 | $27.32 | $27.4 | $26.65 | 340,710 | 05-02-2024 |
$26.95 | $26.28 | $26.95 | $27.1199 | $26.27 | 449,862 | 05-01-2024 |
$26.25 | $25.86 | $26.25 | $26.31 | $25.44 | 479,759 | 04-30-2024 |
$26.05 | $26.42 | $26.05 | $26.71 | $26.04 | 540,326 | 04-29-2024 |
$26.33 | $25.34 | $26.33 | $26.37 | $25.33 | 304,606 | 04-26-2024 |
$25.5 | $25.7 | $25.5 | $26 | $25.33 | 305,838 | 04-25-2024 |
$25.9 | $26.65 | $25.9 | $26.77 | $25.78 | 359,410 | 04-24-2024 |
$26.81 | $26.24 | $26.81 | $27.09 | $26.19 | 497,168 | 04-23-2024 |
$26.1 | $26.19 | $26.1 | $26.67 | $25.735 | 375,229 | 04-22-2024 |
$26.25 | $25.98 | $26.25 | $26.34 | $25.91 | 448,972 | 04-19-2024 |
News, Short Squeeze, Breakout and More Instantly...
Pacira BioSciences Inc. Company Name:
PCRX Stock Symbol:
NASDAQ Market:
Pacira BioSciences Inc. Website:
TAMPA, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced the pricing of $250.0 million aggregate principal amount of convertible senior notes due 2029 (the “notes”) in a private placement to qualified institutional buyers pursuant to Rule...
TAMPA, Fla., May 08, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced that it intends to offer, subject to market and other conditions, $250.0 million aggregate principal amount of convertible senior notes due 2029 (the “notes”) in a private placement...
-- Conference call today at 4:30 p.m. ET -- TAMPA, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported financial results for the first quarter of...